Deeter Investments’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.87M Buy
+169,740
New +$2.54M 0.4% 58

Other funds holding SMMT

Deeter Investments's SMMT Position: Q3 2026 in Review

Deeter Investments opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 169,740 shares worth $2.87M. The stake represents 0.4% of the portfolio and ranks #58 among its holdings.

298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Deeter Investments held 169,740 shares of Summit Therapeutics worth $2.87M as of Q3 2026.
  • Summit Therapeutics was a new Deeter Investments position in Q3 2026.
  • Summit Therapeutics made up 0.4% of Deeter Investments's portfolio in Q3 2026, its #58 holding.
  • 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Deeter Investments's 13F filing for Q3 2026, filed 16 Nov 2026.